Journal article
Community norms for the Eating Disorder Examination Questionnaire among cisgender gay men
Jason M Nagata, Matthew R Capriotti, Stuart B Murray, Emilio J Compte, Scott Griffiths, Kirsten Bibbins-Domingo, Juno Obedin-Maliver, Annesa Flentje, Micah E Lubensky, Mitchell R Lunn
EUROPEAN EATING DISORDERS REVIEW | WILEY | Published : 2019
DOI: 10.1002/erv.2708
Abstract
OBJECTIVE: Prior norms of the Eating Disorders Examination Questionnaire (EDE-Q) among men have not considered sexual orientation. This study's objective was to assess EDE-Q community norms among cisgender gay men. METHOD: Participants were 978 self-identified cisgender gay men from The PRIDE Study recruited in 2018. RESULTS: We present mean scores and standard deviations for the EDE-Q among cisgender gay men ages 18-82. Among cisgender gay men, 4.0% scored in the clinically significant range on the global score, 5.7% on the restraint, 2.1% on the eating concern, 10.5% on the weight concern, and 21.4% on the shape concern subscales of the EDE-Q. The global score as well as weight and shape c..
View full abstractGrants
Awarded by American Heart Association
Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awarded by National Health and Medical Research Council
Awarded by National Institute of Diabetes and Digestive and Kidney Diseases
Awarded by National Institute of Mental Health
Awarded by Patient-Centered Outcomes Research Institute
Awarded by National Institute on Drug Abuse
Awarded by Pediatric Scientist Development Program - American Academy of Pediatrics
Awarded by American Heart Association Career Development
Awarded by National Institutes of Health
Awarded by National Health and Medical Research Council Early Career Fellowship
Awarded by National Institute of Diabetes, Digestive, and Kidney Disorders
Funding Acknowledgements
American Heart Association, Grant/Award Number: CDA34760281; Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant/Award Number: K12 HD000850; National Health and Medical Research Council, Grant/Award Number: 1121538; National Institute of Diabetes and Digestive and Kidney Diseases, Grant/Award Number: K12DK111028; National Institute of Mental Health, Grant/Award Number: K23 MH115184; Patient-Centered Outcomes Research Institute, Grant/Award Number: PPRN-1501-26848; National Institute on Drug Abuse, Grant/Award Number: K23DA039800; American Pediatric Society; American Academy of PediatricsJN is supported by the Pediatric Scientist Development Program (K12 HD000850) supported by the American Academy of Pediatrics and American Pediatric Society and the American Heart Association Career Development (CDA34760281). MC was supported by a Clinical Research Training Fellowship from the American Academy of Neurology and the Tourette Association of America. SBM was supported by the National Institutes of Health (K23 MH115184). EJC was supported by a postdoctoral research fellowship from the Fulbright Commission and the Argentine Ministry of Education. SG is supported by a National Health and Medical Research Council Early Career Fellowship (1121538). JOM was partially supported by K12DK111028 from the National Institute of Diabetes, Digestive, and Kidney Disorders. AF was supported by the National Institute on Drug Abuse (K23DA039800). Research reported in this article was partially funded through a Patient-Centered Outcomes Research Institute (www.pcori.org; PPRN-150126848) to MRL. The statements in this article are solely the responsibility of the authors and do not necessarily represent the views of Patient-Centered Outcomes Research Institute, its Board of Governors or Methodology Committee, or the National Institutes of Health.